Home
About Us
R&D
Jobs
News
Contact Us
Slide One
Protinhi
News
Slide One
Protinhi
News
E1.4M-granted-for-pan-corona-antiviral-preclinical-development
juli 3, 2023
Prev
Previous
IMM and consortium partners Protinhi Therapeutics and Artemis launched the preclinical development of pan-corona antiviral against COVID-19 and other corona viral threats
